312 related articles for article (PubMed ID: 16473348)
1. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
2. Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.
Desaphy JF; De Luca A; Didonna MP; George AL; Camerino Conte D
J Physiol; 2004 Jan; 554(Pt 2):321-34. PubMed ID: 14608015
[TBL] [Abstract][Full Text] [Related]
3. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
Wang GK; Russell C; Wang SY
J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091
[TBL] [Abstract][Full Text] [Related]
4. Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide.
Nagatomo T; January CT; Makielski JC
Mol Pharmacol; 2000 Jan; 57(1):101-7. PubMed ID: 10617684
[TBL] [Abstract][Full Text] [Related]
5. State-dependent trapping of flecainide in the cardiac sodium channel.
Ramos E; O'leary ME
J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
[TBL] [Abstract][Full Text] [Related]
6. High-affinity blockade of voltage-operated skeletal muscle sodium channels by 2,6-dimethyl-4-chlorophenol.
Haeseler G; Gudehus S; Bufler J; Dengler R; Leuwer M
Eur J Anaesthesiol; 2006 Mar; 23(3):190-6. PubMed ID: 16430789
[TBL] [Abstract][Full Text] [Related]
7. Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.
Wang GK; Russell C; Wang SY
J Physiol; 2004 Feb; 554(Pt 3):621-33. PubMed ID: 14608007
[TBL] [Abstract][Full Text] [Related]
8. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.
De Luca A; Natuzzi F; Desaphy JF; Loni G; Lentini G; Franchini C; Tortorella V; Camerino DC
Mol Pharmacol; 2000 Feb; 57(2):268-77. PubMed ID: 10648636
[TBL] [Abstract][Full Text] [Related]
10. Interaction of high concentrations of riluzole with recombinant skeletal muscle sodium channels and adult-type nicotinic receptor channels.
Mohammadi B; Lang N; Dengler R; Bufler J
Muscle Nerve; 2002 Oct; 26(4):539-45. PubMed ID: 12362421
[TBL] [Abstract][Full Text] [Related]
11. The effects of class Ic antiarrhythmics on tetrodotoxin-resistant Na+ currents in rat sensory neurons.
Osawa Y; Oda A; Iida H; Tanahashi S; Dohi S
Anesth Analg; 2004 Aug; 99(2):464-71, table of contents. PubMed ID: 15271726
[TBL] [Abstract][Full Text] [Related]
12. Assessing use-dependent inhibition of the cardiac Na(+/-) current (I(Na)) in the PatchXpress automated patch clamp.
Penniman JR; Kim DC; Salata JJ; Imredy JP
J Pharmacol Toxicol Methods; 2010; 62(2):107-18. PubMed ID: 20601018
[TBL] [Abstract][Full Text] [Related]
13. NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres.
Friedrich O; V Wegner F; Wink M; Fink RH
Br J Pharmacol; 2007 May; 151(1):82-93. PubMed ID: 17351660
[TBL] [Abstract][Full Text] [Related]
14. Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na(+) channels.
Franchini C; Carocci A; Catalano A; Cavalluzzi MM; Corbo F; Lentini G; Scilimati A; Tortorella P; Camerino DC; De Luca A
J Med Chem; 2003 Nov; 46(24):5238-48. PubMed ID: 14613326
[TBL] [Abstract][Full Text] [Related]
15. Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita.
Fleischhauer R; Mitrovic N; Deymeer F; Lehmann-Horn F; Lerche H
Pflugers Arch; 1998 Oct; 436(5):757-65. PubMed ID: 9716710
[TBL] [Abstract][Full Text] [Related]
16. Differential contribution of sodium channel subtypes to action potential generation in unmyelinated human C-type nerve fibers.
Lang PM; Hilmer VB; Grafe P
Anesthesiology; 2007 Sep; 107(3):495-501. PubMed ID: 17721253
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase.
Lee HC; Patel MK; Mistry DJ; Wang Q; Reddy S; Moorman JR; Mounsey JP
Physiol Genomics; 2003 Jan; 12(2):147-57. PubMed ID: 12454205
[TBL] [Abstract][Full Text] [Related]
18. The cutaneous analgesic effect of class I antiarrhythmic drugs.
Tzeng JI; Cheng KI; Huang KL; Chen YW; Chu KS; Chu CC; Wang JJ
Anesth Analg; 2007 Apr; 104(4):955-8. PubMed ID: 17377113
[TBL] [Abstract][Full Text] [Related]
19. A common SCN5A variant alters the responsiveness of human sodium channels to class I antiarrhythmic agents.
Shuraih M; Ai T; Vatta M; Sohma Y; Merkle EM; Taylor E; Li Z; Xi Y; Razavi M; Towbin JA; Cheng J
J Cardiovasc Electrophysiol; 2007 Apr; 18(4):434-40. PubMed ID: 17331104
[TBL] [Abstract][Full Text] [Related]
20. Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis.
Cannon SC; Corey DP
J Physiol; 1993 Jul; 466():501-20. PubMed ID: 8105077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
